Skip to main content
SpringerLink
Log in

Drug Treatment of Epilepsy Neuropsychiatric Comorbidities in Children

  • Review Article
  • Published:
Pediatric Drugs Aims and scope Submit manuscript

Abstract

There is increasing recognition that epilepsy can be associated with a broad spectrum of comorbidities. While epileptic seizures are an essential element of epilepsy in children, there is a spectrum of neurological, mental health and cognitive disorders that add to the disease burden of childhood epilepsy resulting in a decreased quality of life. The most common comorbid conditions in childhood epilepsy include depression, anxiety, autism spectrum disorders, sleep disorders, attention deficits, cognitive impairment, and migraine. While epilepsy can result in comorbidities, many of the comorbidities of childhood have a bi-directional association, with the comorbid condition increasing risk for epilepsy and epilepsy increasing the risk for the comorbid condition. The bidirectional feature of epilepsy and the comorbidities suggest a common underlying pathological basis for both the seizures and comorbid condition. While recognition of the comorbid conditions of pediatric epilepsies is increasing, there has been a lag in the development of effective therapies partly out of concern that drugs used to treat the comorbid conditions could increase seizure susceptibility. There is now some evidence that most drugs used for comorbid conditions are safe and do not lower seizure threshold. Unfortunately, the evidence showing drugs are effective in treating many of the childhood comorbidities of epilepsy is quite limited. There is a great need for randomized, placebo-controlled drug trials for efficacy and safety in the treatment of comorbidities of childhood epilepsy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Berg AT. Epilepsy, cognition, and behavior: The clinical picture. Epilepsia. 2011;52(Suppl 1):7–12.

    PubMed  PubMed Central  Google Scholar 

  2. Tellez-Zenteno JF, Patten SB, Jetté N, Williams J, Wiebe S. Psychiatric comorbidity in epilepsy: a population-based analysis. Epilepsia. 2007;48(12):2336–44.

    PubMed  Google Scholar 

  3. Fisher RS, Acevedo C, Arzimanoglou A, Bogacz A, Cross JH, Elger CE, et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia. 2014;55(4):475–82.

    PubMed  Google Scholar 

  4. Feinstein AR. The pre-therapeutic classification of co-morbidity in chronic disease. J Chronic Dis. 1970;23(7):455–68.

    CAS  PubMed  Google Scholar 

  5. Welton JM, Walker C, Riney K, Ng A, Todd L, D’Souza WJ. Quality of life and its association with comorbidities and adverse events from antiepileptic medications: online survey of patients with epilepsy in Australia. Epilepsy Behav. 2020;104(Pt A):106856.

    PubMed  Google Scholar 

  6. Morningstar M, Hung A, Mattson WI, Gedela S, Ostendorf AP, Nelson EE. Internalizing symptoms in intractable pediatric epilepsy: Structural and functional brain correlates. Epilepsy Behav. 2020;103(Pt A):106845.

    PubMed  Google Scholar 

  7. Riechmann J, Willems LM, Boor R, Kieslich M, Knake S, Langner C, et al. Quality of life and correlating factors in children, adolescents with epilepsy, and their caregivers: a cross-sectional multicenter study from Germany. Seizure. 2019;69:92–8.

    PubMed  Google Scholar 

  8. Puka K, Ferro MA, Camfield CS, Levin SD, Smith ML, Wiebe S, et al. Trajectories of quality of life 10 years following a diagnosis of epilepsy in childhood. Epilepsia. 2020;61(7):1453–63.

    PubMed  Google Scholar 

  9. IOM (Institute of Medicine). Epilepsy across the spectrum: promoting health and understanding. Washington, DC: The National Academies Press; 2012.

    Google Scholar 

  10. Austin JK, Harezlak J, Dunn DW, Huster GA, Rose DF, Ambrosius WT. Behavior problems in children before first recognized seizures. Pediatrics. 2001;107(1):115–22.

    CAS  PubMed  Google Scholar 

  11. Dunn DW, Austin JK, Huster GA. Behaviour problems in children with new-onset epilepsy. Seizure. 1997;6(4):283–7.

    PubMed  Google Scholar 

  12. Kanner AM. Psychiatric comorbidity in patients with developmental disorders and epilepsy: a practical approach to its diagnosis and treatment. Epilepsy Behav. 2002;3(6s1):7–13.

    PubMed  Google Scholar 

  13. Lewis A. Melancholia: a historical review. J Mental Sci. 1934;80:1.

    Google Scholar 

  14. The Temkin O, Sickness Falling. A history of epilepsy from the Greeks to the beginning of modern neurology. Baltimore: Johns Hopkins Press; 1971.

    Google Scholar 

  15. Swinkels WA, Kuyk J, van Dyck R, Spinhoven P. Psychiatric comorbidity in epilepsy. Epilepsy Behav. 2005;7(1):37–50.

    CAS  PubMed  Google Scholar 

  16. Dunn DW, Austin JK, Perkins SM. Prevalence of psychopathology in childhood epilepsy: categorical and dimensional measures. Dev Med Child Neurol. 2009;51(5):364–72.

    PubMed  PubMed Central  Google Scholar 

  17. Salayev KA, Sanne B, Salayev R. Psychiatric and behavioural problems in children and adolescents with epilepsy. East Asian Arch Psychiatry. 2017;27(3):106–14.

    CAS  PubMed  Google Scholar 

  18. Gaitatzis A, Carroll K, Majeed A, Sander JW. The epidemiology of the comorbidity of epilepsy in the general population. Epilepsia. 2004;45(12):1613–22.

    PubMed  Google Scholar 

  19. Gaitatzis A, Trimble MR, Sander JW. The psychiatric comorbidity of epilepsy. Acta Neurol Scand. 2004;110(4):207–20.

    CAS  PubMed  Google Scholar 

  20. Ekinci O, Titus JB, Rodopman AA, Berkem M, Trevathan E. Depression and anxiety in children and adolescents with epilepsy: prevalence, risk factors, and treatment. Epilepsy Behav. 2009;14(1):8–18.

    PubMed  Google Scholar 

  21. Ott D, Caplan R, Guthrie D, Siddarth P, Komo S, Shields WD, et al. Measures of psychopathology in children with complex partial seizures and primary generalized epilepsy with absence. J Am Acad Child Adolesc Psychiatry. 2001;40(8):907–14.

    CAS  PubMed  Google Scholar 

  22. Ott D, Siddarth P, Gurbani S, Koh S, Tournay A, Shields WD, et al. Behavioral disorders in pediatric epilepsy: unmet psychiatric need. Epilepsia. 2003;44(4):591–7.

    PubMed  Google Scholar 

  23. Plioplys S. Depression in children and adolescents with epilepsy. Epilepsy Behav. 2003;4(Suppl 3):S39–45.

    PubMed  Google Scholar 

  24. Piazzini A, Canevini MP, Maggiori G, Canger R. Depression and anxiety in patients with epilepsy. Epilepsy Behav. 2001;2(5):481–9.

    PubMed  Google Scholar 

  25. Ettinger AB, Weisbrot DM, Nolan EE, Gadow KD, Vitale SA, Andriola MR, et al. Symptoms of depression and anxiety in pediatric epilepsy patients. Epilepsia. 1998;39(6):595–9.

    CAS  PubMed  Google Scholar 

  26. Williams J, Steel C, Sharp GB, DelosReyes E, Phillips T, Bates S, et al. Anxiety in children with epilepsy. Epilepsy Behav. 2003;4(6):729–32.

    PubMed  Google Scholar 

  27. Caplan R, Siddarth P, Gurbani S, Hanson R, Sankar R, Shields WD. Depression and anxiety disorders in pediatric epilepsy. Epilepsia. 2005;46(5):720–30.

    PubMed  Google Scholar 

  28. Reilly C, Agnew R, Neville BG. Depression and anxiety in childhood epilepsy: a review. Seizure. 2011;20(8):589–97.

    PubMed  Google Scholar 

  29. Yang C, Hao Z, Mao Y, Xu Q, Zhao L, Zhang LL. Depression in children with epilepsy from western China: a cross-sectional survey. Medicine (Baltimore). 2020;99(24):e20647.

    PubMed  PubMed Central  Google Scholar 

  30. Kalin NH. The critical relationship between anxiety and depression. Am J Psychiatry. 2020;177(5):365–7.

    PubMed  Google Scholar 

  31. Tamer SK. The pediatric non-epileptic seizure. Indian J Pediatr. 1997;64(5):671–6.

    CAS  PubMed  Google Scholar 

  32. Verrotti A, Agostinelli S, Mohn A, Manco R, Coppola G, Franzoni E, et al. Clinical features of psychogenic non-epileptic seizures in prepubertal and pubertal patients with idiopathic epilepsy. Neurol Sci. 2009;30(4):319–23.

    PubMed  Google Scholar 

  33. Forsgren L, Nystrom L. An incident case-referent study of epileptic seizures in adults. Epilepsy Res. 1990;6(1):66–81.

    CAS  PubMed  Google Scholar 

  34. Hesdorffer DC, Hauser WA, Annegers JF, Cascino G. Major depression is a risk factor for seizures in older adults. Ann Neurol. 2000;47(2):246–9.

    CAS  PubMed  Google Scholar 

  35. Hesdorffer DC, Hauser WA, Olafsson E, Ludvigsson P, Kjartansson O. Depression and suicide attempt as risk factors for incident unprovoked seizures. Ann Neurol. 2006;59(1):35–41.

    PubMed  Google Scholar 

  36. Jones JE, Watson R, Sheth R, Caplan R, Koehn M, Seidenberg M, et al. Psychiatric comorbidity in children with new onset epilepsy. Dev Med Child Neurol. 2007;49(7):493–7.

    PubMed  Google Scholar 

  37. Hitiris N, Mohanraj R, Norrie J, Sills GJ, Brodie MJ. Predictors of pharmacoresistant epilepsy. Epilepsy Res. 2007;75(2–3):192–6.

    CAS  PubMed  Google Scholar 

  38. Cramer JA, Blum D, Reed M, Fanning K. The influence of comorbid depression on seizure severity. Epilepsia. 2003;44(12):1578–84.

    PubMed  Google Scholar 

  39. Montgomery SA. Antidepressants and seizures: emphasis on newer agents and clinical implications. Int J Clin Pract. 2005;59(12):1435–40.

    CAS  PubMed  Google Scholar 

  40. Rosenstein DL, Nelson JC, Jacobs SC. Seizures associated with antidepressants: a review. J Clin Psychiatry. 1993;54(8):289–99.

    CAS  PubMed  Google Scholar 

  41. Kanner AM, Kozak AM, Frey M. The use of sertraline in patients with epilepsy: is it safe? Epilepsy Behav. 2000;1(2):100–5.

    PubMed  Google Scholar 

  42. Thomé-Souza MS, Kuczynski E, Valente KD. Sertraline and fluoxetine: safe treatments for children and adolescents with epilepsy and depression. Epilepsy Behav. 2007;10(3):417–25.

    PubMed  Google Scholar 

  43. Alper K, Schwartz KA, Kolts RL, Khan A. Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reports. Biol Psychiatry. 2007;62(4):345–54.

    PubMed  Google Scholar 

  44. Pesola GR, Avasarala J. Bupropion seizure proportion among new-onset generalized seizures and drug related seizures presenting to an emergency department. J Emerg Med. 2002;22(3):235–9.

    PubMed  Google Scholar 

  45. Górska N, Słupski J, Cubała WJ, Wiglusz MS, Gałuszko-Węgielnik M. Antidepressants in epilepsy. Neurol Neurochir Pol. 2018;52(6):657–61.

    PubMed  Google Scholar 

  46. Davidson J. Seizures and bupropion: a review. J Clin Psychiatry. 1989;50(7):256–61.

    CAS  PubMed  Google Scholar 

  47. Dunner DL, Zisook S, Billow AA, Batey SR, Johnston JA, Ascher JA. A prospective safety surveillance study for bupropion sustained-release in the treatment of depression. J Clin Psychiatry. 1998;59(7):366–73.

    CAS  PubMed  Google Scholar 

  48. Jefferson JW, Pradko JF, Muir KT. Bupropion for major depressive disorder: pharmacokinetic and formulation considerations. Clin Ther. 2005;27(11):1685–95.

    CAS  PubMed  Google Scholar 

  49. Jonas JM, Cohon MS. A comparison of the safety and efficacy of alprazolam versus other agents in the treatment of anxiety, panic, and depression: a review of the literature. J Clin Psychiatry. 1993;54(Suppl):25–45 (discussion 6–8).

    PubMed  Google Scholar 

  50. Noyes R Jr, Perry PJ, Crowe RR, Coryell WH, Clancy J, Yamada T, et al. Seizures following the withdrawal of alprazolam. J Nerv Ment Dis. 1986;174(1):50–2.

    PubMed  Google Scholar 

  51. Naylor MW, Grunhaus L, Cameron O. Myoclonic seizures after abrupt withdrawal from phenelzine and alprazolam. J Nerv Ment Dis. 1987;175(2):111–4.

    CAS  PubMed  Google Scholar 

  52. Dunn DW. Should pediatric neurologists play a role in the management of the most common psychiatric comorbidities in children with epilepsy? Practical considerations. Epilepsy Behav. 2019;98(Pt B):314–7.

    PubMed  Google Scholar 

  53. Richerson GB, Buchanan GF. The serotonin axis: shared mechanisms in seizures, depression, and SUDEP. Epilepsia. 2011;52(Suppl 1):28–38.

    PubMed  PubMed Central  Google Scholar 

  54. Kanner AM. Depression and epilepsy: a bidirectional relation? Epilepsia. 2011;52(Suppl 1):21–7.

    PubMed  Google Scholar 

  55. Bagdy G, Kecskemeti V, Riba P, Jakus R. Serotonin and epilepsy. J Neurochem. 2007;100(4):857–73.

    CAS  PubMed  Google Scholar 

  56. Kilian M, Frey HH. Central monoamines and convulsine thresholds in mice and rats. Neuropharmacology. 1973;12(7):681–92.

    CAS  PubMed  Google Scholar 

  57. Buterbaugh GG. Effect of drugs modifying central serotonergic function on the response of extensor and nonextensor rats to maximal electroshock. Life Sci. 1978;23(24):2393–404.

    CAS  PubMed  Google Scholar 

  58. Browning RA, Hoffmann WE, Simonton RL. Changes in seizure susceptibility after intracerebral treatment with 5,7-dihydroxytryptamine: role of serotonergic neurons. Ann N Y Acad Sci. 1978;305:437–56.

    CAS  PubMed  Google Scholar 

  59. Statnick MA, Maring-Smith ML, Clough RW, Wang C, Dailey JW, Jobe PC, et al. Effect of 5,7-dihydroxytryptamine on audiogenic seizures in genetically epilepsy-prone rats. Life Sci. 1996;59(21):1763–71.

    CAS  PubMed  Google Scholar 

  60. Yan QS, Jobe PC, Cheong JH, Ko KH, Dailey JW. Role of serotonin in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats. Naunyn Schmiedebergs Arch Pharmacol. 1994;350(2):149–52.

    CAS  PubMed  Google Scholar 

  61. Brennan TJ, Seeley WW, Kilgard M, Schreiner CE, Tecott LH. Sound-induced seizures in serotonin 5-HT2c receptor mutant mice. Nat Genet. 1997;16(4):387–90.

    CAS  PubMed  Google Scholar 

  62. Sarnyai Z, Sibille EL, Pavlides C, Fenster RJ, McEwen BS, Toth M. Impaired hippocampal-dependent learning and functional abnormalities in the hippocampus in mice lacking serotonin(1A) receptors. Proc Natl Acad Sci USA. 2000;97(26):14731–6.

    CAS  PubMed  Google Scholar 

  63. Toczek MT, Carson RE, Lang L, Ma Y, Spanaki MV, Der MG, et al. PET imaging of 5-HT1A receptor binding in patients with temporal lobe epilepsy. Neurology. 2003;60(5):749–56.

    CAS  PubMed  Google Scholar 

  64. Giovacchini G, Toczek MT, Bonwetsch R, Bagic A, Lang L, Fraser C, et al. 5-HT 1A receptors are reduced in temporal lobe epilepsy after partial-volume correction. J Nucl Med. 2005;46(7):1128–35.

    PubMed  PubMed Central  Google Scholar 

  65. Merlet I, Ostrowsky K, Costes N, Ryvlin P, Isnard J, Faillenot I, et al. 5-HT1A receptor binding and intracerebral activity in temporal lobe epilepsy: an [18F]MPPF-PET study. Brain. 2004;127(Pt 4):900–13.

    PubMed  Google Scholar 

  66. Theodore WH. Does serotonin play a role in epilepsy? Epilepsy Curr. 2003;3(5):173–7.

    PubMed  PubMed Central  Google Scholar 

  67. Isaac M. Serotonergic 5-HT2C receptors as a potential therapeutic target for the design antiepileptic drugs. Curr Top Med Chem. 2005;5(1):59–67.

    CAS  PubMed  Google Scholar 

  68. Aad G, Abbott B, Abdallah J, Abdelalim AA, Abdesselam A, Abdinov O, et al. Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett. 2010;105(16):161801.

    CAS  PubMed  Google Scholar 

  69. Dailey JW, Reith ME, Yan QS, Li MY, Jobe PC. Carbamazepine increases extracellular serotonin concentration: lack of antagonism by tetrodotoxin or zero Ca2+. Eur J Pharmacol. 1997;328(2–3):153–62.

    CAS  PubMed  Google Scholar 

  70. Okada M, Kaneko S, Hirano T, Ishida M, Kondo T, Otani K, et al. Effects of zonisamide on extracellular levels of monoamine and its metabolite, and on Ca2+ dependent dopamine release. Epilepsy Res. 1992;13(2):113–9.

    CAS  PubMed  Google Scholar 

  71. Bonnycastle DD, Giarman NJ, Paasonen MK. Anticonvulsant compounds and 5-hydroxytryptamine in rat brain. Br J Pharmacol Chemother. 1957;12(2):228–31.

    CAS  PubMed  PubMed Central  Google Scholar 

  72. Favale E, Rubino V, Mainardi P, Lunardi G, Albano C. Anticonvulsant effect of fluoxetine in humans. Neurology. 1995;45(10):1926–7.

    CAS  PubMed  Google Scholar 

  73. Favale E, Audenino D, Cocito L, Albano C. The anticonvulsant effect of citalopram as an indirect evidence of serotonergic impairment in human epileptogenesis. Seizure. 2003;12(5):316–8.

    CAS  PubMed  Google Scholar 

  74. Specchio LM, Iudice A, Specchio N, La Neve A, Spinelli A, Galli R, et al. Citalopram as treatment of depression in patients with epilepsy. Clin Neuropharmacol. 2004;27(3):133–6.

    CAS  PubMed  Google Scholar 

  75. Sourbron J, Schneider H, Kecskés A, Liu Y, Buening EM, Lagae L, et al. Serotonergic modulation as effective treatment for Dravet syndrome in a zebrafish mutant model. ACS Chem Neurosci. 2016;7(5):588–98.

    CAS  PubMed  Google Scholar 

  76. Lagae L, Sullivan J, Knupp K, Laux L, Polster T, Nikanorova M, et al. Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial. Lancet. 2020;394(10216):2243–54.

    Google Scholar 

  77. Martin P, de Witte PAM, Maurice T, Gammaitoni A, Farfel G, Galer B. Fenfluramine acts as a positive modulator of sigma-1 receptors. Epilepsy Behav. 2020;105:106989.

    PubMed  Google Scholar 

  78. Maguire MJ, Weston J, Singh J, Marson AG. Antidepressants for people with epilepsy and depression. Cochrane Database Syst Rev. 2014;2014(12):5 (Cd010682).

    Google Scholar 

  79. Bosak M, Słowik A, Iwańska A, Lipińska M, Turaj W. Co-medication and potential drug interactions among patients with epilepsy. Seizure. 2019;66:47–52.

    PubMed  Google Scholar 

  80. Nemeroff CB, DeVane CL, Pollock BG. Newer antidepressants and the cytochrome P450 system. Am J Psychiatry. 1996;153(3):311–20.

    CAS  PubMed  Google Scholar 

  81. Harden CL. The co-morbidity of depression and epilepsy: epidemiology, etiology, and treatment. Neurology. 2002;59(6 Suppl 4):S48–55.

    CAS  PubMed  Google Scholar 

  82. Grimsley SR, Jann MW, Carter JG, D’Mello AP, D’Souza MJ. Increased carbamazepine plasma concentrations after fluoxetine coadministration. Clin Pharmacol Ther. 1991;50(1):10–5.

    CAS  PubMed  Google Scholar 

  83. Martinelli V, Bocchetta A, Palmas AM, Del Zompo M. An interaction between carbamazepine and fluvoxamine. Br J Clin Pharmacol. 1993;36(6):615–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  84. Ashton AK, Wolin RE. Nefazodone-induced carbamazepine toxicity. Am J Psychiatry. 1996;153(5):733.

    CAS  PubMed  Google Scholar 

  85. Ereshefsky L. Drug-drug interactions involving antidepressants: focus on venlafaxine. J Clin Psychopharmacol. 1996;16(3 Suppl 2):37S–50S (discussion S-3S).

    CAS  PubMed  Google Scholar 

  86. Dunn DW, Austin JK, Harezlak J, Ambrosius WT. ADHD and epilepsy in childhood. Dev Med Child Neurol. 2003;45(1):50–4.

    PubMed  Google Scholar 

  87. Cohen R, Senecky Y, Shuper A, Inbar D, Chodick G, Shalev V, et al. Prevalence of epilepsy and attention-deficit hyperactivity (ADHD) disorder: a population-based study. J Child Neurol. 2013;28(1):120–3.

    PubMed  Google Scholar 

  88. Verrotti A, Moavero R, Panzarino G, Di Paolantonio C, Rizzo R, Curatolo P. The challenge of pharmacotherapy in children and adolescents with epilepsy-ADHD comorbidity. Clin Drug Investig. 2018;38(1):1–8.

    CAS  PubMed  Google Scholar 

  89. Parisi P, Moavero R, Verrotti A, Curatolo P. Attention deficit hyperactivity disorder in children with epilepsy. Brain Dev. 2010;32(1):10–6.

    PubMed  Google Scholar 

  90. Fastenau PS, Jianzhao S, Dunn DW, Austin JK. Academic underachievement among children with epilepsy: proportion exceeding psychometric criteria for learning disability and associated risk factors. J Learn Disabil. 2008;41(3):195–207.

    PubMed  PubMed Central  Google Scholar 

  91. Brikell I, Ghirardi L, D’Onofrio BM, Dunn DW, Almqvist C, Dalsgaard S, et al. Familial liability to epilepsy and attention-deficit/hyperactivity disorder: a nationwide cohort study. Biol Psychiatry. 2018;83(2):173–80.

    PubMed  Google Scholar 

  92. Chou IC, Chang YT, Chin ZN, Muo CH, Sung FC, Kuo HT, et al. Correlation between epilepsy and attention deficit hyperactivity disorder: a population-based cohort study. PLoS One. 2013;8(3):e57926.

    CAS  PubMed  PubMed Central  Google Scholar 

  93. Wiggs KK, Chang Z, Quinn PD, Hur K, Gibbons R, Dunn D, et al. Attention-deficit/hyperactivity disorder medication and seizures. Neurology. 2018;90(13):e1104–10.

    PubMed  PubMed Central  Google Scholar 

  94. Ekinci O, Okuyaz Ç, Erdoğan S, Gunes S, Ekinci N, Kalınlı M, et al. Attention-deficit hyperactivity disorder (ADHD) in epilepsy and primary ADHD: differences in symptom dimensions and quality of life. J Child Neurol. 2017;32(14):1083–91.

    PubMed  Google Scholar 

  95. Alibas H, Koytak PK, Ekinci G, Uluc K. A case with leukoencephalopathy with brainstem and spinal cord involvement and elevated lactate (LBSL) with its Characteristic Clinical and Neuroimaging Findings. Clin Neuroradiol. 2014;24(3):297–300.

    CAS  PubMed  Google Scholar 

  96. Hesdorffer DC, Ludvigsson P, Olafsson E, Gudmundsson G, Kjartansson O, Hauser WA. ADHD as a risk factor for incident unprovoked seizures and epilepsy in children. Arch Gen Psychiatry. 2004;61(7):731–6.

    PubMed  Google Scholar 

  97. Williams J, Griebel ML, Dykman RA. Neuropsychological patterns in pediatric epilepsy. Seizure. 1998;7:223–8.

    CAS  PubMed  Google Scholar 

  98. Holtmann M, Becker K, Kentner-Figura B, Schmidt MH. Increased frequency of rolandic spikes in ADHD children. Epilepsia. 2003;44(9):1241–4.

    PubMed  Google Scholar 

  99. Atkinson M, Hollis C. NICE guideline: attention deficit hyperactivity disorder. Arch Dis Child Educ Pract Ed. 2010;95(1):24–7.

    CAS  PubMed  Google Scholar 

  100. Wolraich M, Brown L, Brown RT, DuPaul G, Earls M, Feldman HM, et al. ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. 2011;128(5):1007–22.

    PubMed  Google Scholar 

  101. Faraone SV. The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities. Neurosci Biobehav Rev. 2018;87:255–70.

    CAS  PubMed  Google Scholar 

  102. Reed VA, Buitelaar JK, Anand E, Day KA, Treuer T, Upadhyaya HP, et al. The safety of atomoxetine for the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a comprehensive review of over a decade of research. CNS Drugs. 2016;30(7):603–28.

    CAS  PubMed  Google Scholar 

  103. Biederman J, Melmed RD, Patel A, McBurnett K, Konow J, Lyne A, et al. A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder. Pediatrics. 2008;121(1):e73–84.

    PubMed  Google Scholar 

  104. Sallee FR, Lyne A, Wigal T, McGough JJ. Long-term safety and efficacy of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2009;19(3):215–26.

    PubMed  Google Scholar 

  105. Jain R, Segal S, Kollins SH, Khayrallah M. Clonidine extended-release tablets for pediatric patients with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2011;50(2):171–9.

    PubMed  Google Scholar 

  106. Bolea-Alamañac B, Nutt DJ, Adamou M, Asherson P, Bazire S, Coghill D, et al. Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: update on recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2014;28(3):179–203.

    PubMed  Google Scholar 

  107. Gorman DA, Gardner DM, Murphy AL, Feldman M, Bélanger SA, Steele MM, et al. Canadian guidelines on pharmacotherapy for disruptive and aggressive behaviour in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, or conduct disorder. Can J Psychiatry. 2015;60(2):62–76.

    PubMed  PubMed Central  Google Scholar 

  108. Faraone SV, Glatt SJ. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes. J Clin Psychiatry. 2010;71(6):754–63.

    PubMed  Google Scholar 

  109. Catalá-López F, Hutton B, Núñez-Beltrán A, Page MJ, Ridao M, Macías Saint-Gerons D, et al. The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: a systematic review with network meta-analyses of randomised trials. PLoS One. 2017;12(7):e0180355.

    PubMed  PubMed Central  Google Scholar 

  110. Faraone SV, Buitelaar J. Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis. Eur Child Adolesc Psychiatry. 2010;19(4):353–64.

    PubMed  Google Scholar 

  111. Joseph A, Ayyagari R, Xie M, Cai S, Xie J, Huss M, et al. Comparative efficacy and safety of attention-deficit/hyperactivity disorder pharmacotherapies, including guanfacine extended release: a mixed treatment comparison. Eur Child Adolesc Psychiatry. 2017;26(8):875–97.

    PubMed  PubMed Central  Google Scholar 

  112. Stuhec M, Munda B, Svab V, Locatelli I. Comparative efficacy and acceptability of atomoxetine, lisdexamfetamine, bupropion and methylphenidate in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis with focus on bupropion. J Affect Disord. 2015;178:149–59.

    CAS  PubMed  Google Scholar 

  113. Park J, Choi HW, Yum MS, Ko TS, Shon SH, Kim HW. Relationship between aggravation of seizures and methylphenidate treatment in subjects with attention-deficit/hyperactivity disorder and epilepsy. J Child Adolesc Psychopharmacol. 2018;28(8):537–46.

    CAS  PubMed  Google Scholar 

  114. Gonzalez-Heydrich J, Whitney J, Waber D, Forbes P, Hsin O, Faraone SV, et al. Adaptive phase I study of OROS methylphenidate treatment of attention deficit hyperactivity disorder with epilepsy. Epilepsy Behav. 2010;18(3):229–37.

    PubMed  PubMed Central  Google Scholar 

  115. Verotti A, Trotta D, Cutarella R, Pascarella R, Morgese G, Chiarelli F. Effects of antiepileptic drugs on evoked potentials in epileptic children. Pediatr Neurol. 2000;23:397–402.

    Google Scholar 

  116. Gonzalez-Heydrich J, Hsin O, Gumlak S, Kimball K, Rober A, Azeem MW, et al. Comparing stimulant effects in youth with ADHD symptoms and epilepsy. Epilepsy Behav. 2014;36:102–7.

    PubMed  PubMed Central  Google Scholar 

  117. Schumann CM, Bloss CS, Barnes CC, Wideman GM, Carper RA, Akshoomoff N, et al. Longitudinal magnetic resonance imaging study of cortical development through early childhood in autism. J Neurosci. 2010;30(12):4419–27.

    CAS  PubMed  PubMed Central  Google Scholar 

  118. Howes OD, Rogdaki M, Findon JL, Wichers RH, Charman T, King BH, et al. Autism spectrum disorder: consensus guidelines on assessment, treatment and research from the British Association for Psychopharmacology. J Psychopharmacol. 2018;32(1):3–29.

    PubMed  Google Scholar 

  119. Ballester P, Richdale AL, Baker EK, Peiró AM. Sleep in autism: a biomolecular approach to aetiology and treatment. Sleep Med Rev. 2020;54:101357.

    CAS  PubMed  Google Scholar 

  120. Kanner L. Autistic disturbances of affective contact. Acta Paedopsychiatr. 1968;35(4):100–36.

    CAS  PubMed  Google Scholar 

  121. Spence SJ, Schneider MT. The role of epilepsy and epileptiform EEGs in autism spectrum disorders. Pediatr Res. 2009;65(6):599–606.

    PubMed  PubMed Central  Google Scholar 

  122. Danielsson S, Gillberg IC, Billstedt E, Gillberg C, Olsson I. Epilepsy in young adults with autism: a prospective population-based follow-up study of 120 individuals diagnosed in childhood. Epilepsia. 2005;46(6):918–23.

    PubMed  Google Scholar 

  123. Anukirthiga B, Mishra D, Pandey S, Juneja M, Sharma N. Prevalence of epilepsy and inter-ictal epileptiform discharges in children with autism and attention-deficit hyperactivity disorder. Indian J Pediatr. 2019;86(10):897–902.

    CAS  PubMed  Google Scholar 

  124. Viscidi EW, Triche EW, Pescosolido MF, McLean RL, Joseph RM, Spence SJ, et al. Clinical characteristics of children with autism spectrum disorder and co-occurring epilepsy. PLoS One. 2013;8(7):e67797.

    CAS  PubMed  PubMed Central  Google Scholar 

  125. Amiet C, Gourfinkel-An I, Bouzamondo A, Tordjman S, Baulac M, Lechat P, et al. Epilepsy in autism is associated with intellectual disability and gender: evidence from a meta-analysis. Biol Psychiatry. 2008;64(7):577–82.

    PubMed  Google Scholar 

  126. Olsson I, Steffenburg S, Gillberg C. Epilepsy in autism and autisticlike conditions. A population-based study. Arch Neurol. 1988;45(6):666–8.

    CAS  PubMed  Google Scholar 

  127. Elia M, Musumeci SA, Ferri R, Bergonzi P. Clinical and neurophysiological aspects of epilepsy in subjects with autism and mental retardation. Am J Ment Retard. 1995;100(1):6–16.

    CAS  PubMed  Google Scholar 

  128. Woolfenden S, Sarkozy V, Ridley G, Coory M, Williams K. A systematic review of two outcomes in autism spectrum disorder—epilepsy and mortality. Dev Med Child Neurol. 2012;54(4):306–12.

    PubMed  Google Scholar 

  129. Tuchman R, Cuccaro M. Epilepsy and autism: neurodevelopmental perspective. Curr Neurol Neurosci Rep. 2011;11(4):428–34.

    PubMed  Google Scholar 

  130. Selassie AW, Wilson DA, Martz GU, Smith GG, Wagner JL, Wannamaker BB. Epilepsy beyond seizure: a population-based study of comorbidities. Epilepsy Res. 2014;108(2):305–15.

    PubMed  Google Scholar 

  131. Reilly C, Atkinson P, Memon A, Jones C, Dabydeen L, Helen Cross J, et al. Autism, ADHD and parent-reported behavioural difficulties in young children with epilepsy. Seizure. 2019;71:233–9.

    PubMed  Google Scholar 

  132. Saemundsen E, Ludvigsson P, Hilmarsdottir I, Rafnsson V. Autism spectrum disorders in children with seizures in the first year of life—a population-based study. Epilepsia. 2007;48(9):1724–30.

    PubMed  Google Scholar 

  133. Saemundsen E, Ludvigsson P, Rafnsson V. Risk of autism spectrum disorders after infantile spasms: a population-based study nested in a cohort with seizures in the first year of life. Epilepsia. 2008;49(11):1865–70.

    PubMed  Google Scholar 

  134. Saemundsen E, Magnússon P, Georgsdóttir I, Egilsson E, Rafnsson V. Prevelance of autisum spectrum disorder in an Icelandic birth control. BMJ Open. 2013;3(6):e002748.

    PubMed  PubMed Central  Google Scholar 

  135. Eeg-Olofsson O, Petersén I, Selldén U. The development of the electroencephalogram in normal children from the age of 1 through 15 years: paroxysmal activity. Neuropädiatrie. 1971;2:375–404.

    CAS  PubMed  Google Scholar 

  136. Hughes JR, Melyn M. EEG and seizures in autistic children and adolescents: further findings with therapeutic implications. Clin EEG Neurosci. 2005;36(1):15–20.

    PubMed  Google Scholar 

  137. Sundelin HE, Larsson H, Lichtenstein P, Almqvist C, Hultman CM, Tomson T, et al. Autism and epilepsy: a population-based nationwide cohort study. Neurology. 2016;87(2):192–7.

    PubMed  PubMed Central  Google Scholar 

  138. Reilly C, Atkinson P, Das KB, Chin RF, Aylett SE, Burch V, et al. Neurobehavioral comorbidities in children with active epilepsy: a population-based study. Pediatrics. 2014;133(6):e1586–93.

    PubMed  Google Scholar 

  139. Austin JK, Caplan R. Behavioral and psychiatric comorbidities in pediatric epilepsy: toward an integrative model. Epilepsia. 2007;48(9):1639–51.

    PubMed  Google Scholar 

  140. Plioplys S, Dunn DW, Caplan R. 10-year research update review: psychiatric problems in children with epilepsy. J Am Acad Child Adolesc Psychiatry. 2007;46(11):1389–402.

    PubMed  Google Scholar 

  141. Frye RE, Rossignol D, Casanova MF, Brown GL, Martin V, Edelson S, et al. A review of traditional and novel treatments for seizures in autism spectrum disorder: findings from a systematic review and expert panel. Front Public Health. 2013;1:31.

    PubMed  PubMed Central  Google Scholar 

  142. Lamy M, Pedapati EV, Dominick KL, Wink LK, Erickson CA. Recent advances in the pharmacological management of behavioral disturbances associated with autism spectrum disorder in children and adolescents. Paediatr Drugs. 2020;22(5):473–83.

    PubMed  Google Scholar 

  143. McCracken JT, McGough J, Shah B, Cronin P, Hong D, Aman MG, et al. Risperidone in children with autism and serious behavioral problems. N Engl J Med. 2002;347(5):314–21.

    CAS  PubMed  Google Scholar 

  144. Erickson CA, Posey DJ, Stigler KA, McDougle CJ. Pharmacologic treatment of autism and related disorders. Pediatr Ann. 2007;36(9):575–85.

    PubMed  Google Scholar 

  145. Shea S, Turgay A, Carroll A, Schulz M, Orlik H, Smith I, et al. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders. Pediatrics. 2004;114(5):e634–41.

    PubMed  Google Scholar 

  146. Potkin SG, Saha AR, Kujawa MJ, Carson WH, Ali M, Stock E, et al. Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder. Arch Gen Psychiatry. 2003;60(7):681–90.

    CAS  PubMed  Google Scholar 

  147. Marcus RN, Owen R, Kamen L, Manos G, McQuade RD, Carson WH, et al. A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder. J Am Acad Child Adolesc Psychiatry. 2009;48(11):1110–9.

    PubMed  Google Scholar 

  148. Owen R, Sikich L, Marcus RN, Corey-Lisle P, Manos G, McQuade RD, et al. Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder. Pediatrics. 2009;124(6):1533–40.

    PubMed  Google Scholar 

  149. Marcus RN, Owen R, Manos G, Mankoski R, Kamen L, McQuade RD, et al. Aripiprazole in the treatment of irritability in pediatric patients (aged 6–17 years) with autistic disorder: results from a 52-week, open-label study. J Child Adolesc Psychopharmacol. 2011;21(3):229–36.

    CAS  PubMed  Google Scholar 

  150. Fallah MS, Shaikh MR, Neupane B, Rusiecki D, Bennett TA, Beyene J. Atypical antipsychotics for irritability in pediatric autism: a systematic review and network meta-analysis. J Child Adolesc Psychopharmacol. 2019;29(3):168–80.

    PubMed  Google Scholar 

  151. Holzhausen SP, Guerreiro MM, Baccin CE, Montenegro MA. Use of risperidone in children with epilepsy. Epilepsy Behav. 2007;10(3):412–6.

    PubMed  Google Scholar 

  152. Górska N, Słupski J, Cubała WJ. Antipsychotic drugs in epilepsy. Neurol Neurochir Pol. 2019;53(6):408–12.

    PubMed  Google Scholar 

  153. Wu CS, Wang SC, Yeh IJ, Liu SK. Comparative risk of seizure with use of first- and second-generation antipsychotics in patients with schizophrenia and mood disorders. J Clin Psychiatry. 2016;77(5):e573–9.

    PubMed  Google Scholar 

  154. Premoli M, Aria F, Bonini SA, Maccarinelli G, Gianoncelli A, Pina SD, et al. Cannabidiol: recent advances and new insights for neuropsychiatric disorders treatment. Life Sci. 2019;224:120–7.

    CAS  PubMed  Google Scholar 

  155. Agarwal R, Burke SL, Maddux M. Current state of evidence of cannabis utilization for treatment of autism spectrum disorders. BMC Psychiatry. 2019;19(1):328.

    PubMed  PubMed Central  Google Scholar 

  156. Nobili L, de Weerd A, Rubboli G, Beniczky S, Derry C, Eriksson S, et al. Standard procedures for the diagnostic pathway of sleep-related epilepsies and comorbid sleep disorders: A European Academy of Neurology, European Sleep Research Society and International League against Epilepsy-Europe consensus review. J Sleep Res. 2020;21:e13184.

    Google Scholar 

  157. Wirrell E, Blackman M, Barlow K, Mah J, Hamiwka L. Sleep disturbances in children with epilepsy compared with their nearest-aged siblings. Dev Med Child Neurol. 2005;47(11):754–9.

    PubMed  Google Scholar 

  158. Halász P, Bódizs R, Ujma PP, Fabó D, Szűcs A. Strong relationship between NREM sleep, epilepsy and plastic functions—a conceptual review on the neurophysiology background. Epilepsy Res. 2019;150:95–105.

    PubMed  Google Scholar 

  159. Kotagal P, Yardi N. The relationship between sleep and epilepsy. Semin Pediatr Neurol. 2008;15(2):42–9.

    PubMed  Google Scholar 

  160. Frauscher B, von Ellenrieder N, Dubeau F, Gotman J. EEG desynchronization during phasic REM sleep suppresses interictal epileptic activity in humans. Epilepsia. 2016;57(6):879–88.

    PubMed  PubMed Central  Google Scholar 

  161. Janz D. Epilepsy with grand mal on awakening and sleep-waking cycle. Clin Neurophysiol. 2000;111(Suppl 2):S103–10.

    PubMed  Google Scholar 

  162. Menghi V, Bisulli F, Tinuper P, Nobili L. Sleep-related hypermotor epilepsy: prevalence, impact and management strategies. Nat Sci Sleep. 2018;10:317–26.

    PubMed  PubMed Central  Google Scholar 

  163. Aricò M, Arigliani E, Giannotti F, Romani M. ADHD and ADHD-related neural networks in benign epilepsy with centrotemporal spikes: a systematic review. Epilepsy Behav. 2020;112:107448.

    PubMed  Google Scholar 

  164. Becker DA, Fennell EB, Carney PR. Daytime behavior and sleep disturbance in childhood epilepsy. Epilepsy Behav. 2004;5(5):708–15.

    PubMed  Google Scholar 

  165. Foldvary-Schaefer N, Grigg-Damberger M. Sleep and epilepsy: what we know, don’t know, and need to know. J Clin Neurophysiol. 2006;23(1):4–20.

    PubMed  Google Scholar 

  166. Cortesi F, Giannotti F, Ottaviano S. Sleep problems and daytime behavior in childhood idiopathic epilepsy. Epilepsia. 1999;40(11):1557–65.

    CAS  PubMed  Google Scholar 

  167. Becker DA, Fennell EB, Carney PR. Sleep disturbance in children with epilepsy. Epilepsy Behav. 2003;4(6):651–8.

    PubMed  Google Scholar 

  168. Stores G, Wiggs L, Campling G. Sleep disorders and their relationship to psychological disturbance in children with epilepsy. Child Care Health Dev. 1998;24(1):5–19.

    CAS  PubMed  Google Scholar 

  169. Owens JA, Moturi S. Pharmacologic treatment of pediatric insomnia. Child Adolesc Psychiatr Clin N Am. 2009;18(4):1001–16.

    PubMed  Google Scholar 

  170. Brown KM, Malow BA. Pediatric Insomnia. Chest. 2016;149(5):1332–9.

    PubMed  Google Scholar 

  171. Hysing M, Sivertsen B, Stormark KM, Elgen I, Lundervold AJ. Sleep in children with chronic illness, and the relation to emotional and behavioral problems–a population-based study. J Pediatr Psychol. 2009;34(6):665–70.

    PubMed  Google Scholar 

  172. Cortese S, Konofal E, Yateman N, Mouren MC, Lecendreux M. Sleep and alertness in children with attention-deficit/hyperactivity disorder: a systematic review of the literature. Sleep. 2006;29(4):504–11.

    PubMed  Google Scholar 

  173. Cortese S, Konofal E, Lecendreux M, Arnulf I, Mouren MC, Darra F, et al. Restless legs syndrome and attention-deficit/hyperactivity disorder: a review of the literature. Sleep. 2005;28(8):1007–13.

    PubMed  Google Scholar 

  174. Roberts RE, Roberts CR, Duong HT. Chronic insomnia and its negative consequences for health and functioning of adolescents: a 12-month prospective study. J Adolesc Health. 2008;42(3):294–302.

    PubMed  Google Scholar 

  175. Ramadan W, Eschenko O, Sara SJ. Hippocampal sharp wave/ripples during sleep for consolidation of associative memory. PLoS One. 2009;4(8):e6697.

    PubMed  PubMed Central  Google Scholar 

  176. Farmer CA, Chilakamarri P, Thurm AE, Swedo SE, Holmes GL, Buckley AW. Spindle activity in young children with autism, developmental delay, or typical development. Neurology. 2018;91(2):e112–22.

    PubMed  PubMed Central  Google Scholar 

  177. Oyanedel CN, Durán E, Niethard N, Inostroza M, Born J. Temporal associations between sleep slow oscillations, spindles and ripples. Eur J Neurosci. 2020. https://doi.org/10.1111/ejn.14906.

    Article  PubMed  Google Scholar 

  178. Diekelmann S, Born J. The memory function of sleep. Nat Rev Neurosci. 2010;11(2):114–26.

    CAS  PubMed  Google Scholar 

  179. Lambert I, Tramoni-Negre E, Lagarde S, Roehri N, Giusiano B, Trebuchon-Da Fonseca A, et al. Hippocampal interictal spikes during sleep impact long-term memory consolidation. Ann Neurol. 2020;87(6):976–87.

    PubMed  Google Scholar 

  180. Bazil CW, Castro LH, Walczak TS. Reduction of rapid eye movement sleep by diurnal and nocturnal seizures in temporal lobe epilepsy. Arch Neurol. 2000;57(3):363–8.

    CAS  PubMed  Google Scholar 

  181. Austin JK, Risinger MW, Beckett LA. Correlates of behavior problems in children with epilepsy. Epilepsia. 1992;33(6):1115–22.

    CAS  PubMed  Google Scholar 

  182. Hoare P. The development of psychiatric disorder among schoolchildren with epilepsy. Dev Med Child Neurol. 1984;26(1):3–13.

    CAS  PubMed  Google Scholar 

  183. Bazil CW. Effects of antiepileptic drugs on sleep structure: are all drugs equal? CNS Drugs. 2003;17(10):719–28.

    CAS  PubMed  Google Scholar 

  184. Jain SV, Glauser TA. Effects of epilepsy treatments on sleep architecture and daytime sleepiness: an evidence-based review of objective sleep metrics. Epilepsia. 2014;55(1):26–37.

    CAS  PubMed  Google Scholar 

  185. Cardenas JF, Rho JM, Ng YT. Reversible lamotrigine-induced neurobehavioral disturbances in children with epilepsy. J Child Neurol. 2010;25(2):182–7.

    PubMed  Google Scholar 

  186. Byars AW, Byars KC, Johnson CS, DeGrauw TJ, Fastenau PS, Perkins S, et al. The relationship between sleep problems and neuropsychological functioning in children with first recognized seizures. Epilepsy Behav. 2008;13(4):607–13.

    PubMed  PubMed Central  Google Scholar 

  187. Foldvary N. Sleep and epilepsy. Curr Treat Options Neurol. 2002;4(2):129–35.

    PubMed  Google Scholar 

  188. Hoeppner JB, Garron DC, Cartwright RD. Self-reported sleep disorder symptoms in epilepsy. Epilepsia. 1984;25(4):434–7.

    CAS  PubMed  Google Scholar 

  189. Malow BA, Weatherwax KJ, Chervin RD, Hoban TF, Marzec ML, Martin C, et al. Identification and treatment of obstructive sleep apnea in adults and children with epilepsy: a prospective pilot study. Sleep Med. 2003;4(6):509–15.

    PubMed  Google Scholar 

  190. Hiscock H, Sciberras E, Mensah F, Gerner B, Efron D, Khano S, et al. Impact of a behavioural sleep intervention on symptoms and sleep in children with attention deficit hyperactivity disorder, and parental mental health: randomised controlled trial. BMJ. 2015;20(350):h68.

    Google Scholar 

  191. Sciberras E, Mulraney M, Mensah F, Oberklaid F, Efron D, Hiscock H. Sustained impact of a sleep intervention and moderators of treatment outcome for children with ADHD: a randomised controlled trial. Psychol Med. 2020;50(2):210–9.

    CAS  PubMed  Google Scholar 

  192. Johnson CR, Turner KS, Foldes E, Brooks MM, Kronk R, Wiggs L. Behavioral parent training to address sleep disturbances in young children with autism spectrum disorder: a pilot trial. Sleep Med. 2013;14(10):995–1004.

    PubMed  PubMed Central  Google Scholar 

  193. Mindell JA, Kuhn B, Lewin DS, Meltzer LJ, Sadeh A. Behavioral treatment of bedtime problems and night wakings in infants and young children. Sleep. 2006;29(10):1263–76.

    PubMed  Google Scholar 

  194. Williams Buckley A, Hirtz D, Oskoui M, Armstrong MJ, Batra A, Bridgemohan C, et al. Practice guideline: treatment for insomnia and disrupted sleep behavior in children and adolescents with autism spectrum disorder: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2020;94(9):392–404.

    PubMed  PubMed Central  Google Scholar 

  195. Goulden KJ, Shinnar S, Koller H, Katz M, Richardson SA. Epilepsy in children with mental retardation: a cohort study. Epilepsia. 1991;32(5):690–7.

    CAS  PubMed  Google Scholar 

  196. Hauser WA, Annegers JF, Kurland LT. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935–1984. Epilepsia. 1993;34(3):453–68.

    CAS  PubMed  Google Scholar 

  197. Richardson SA, Koller H, Katz M, McLaren J. Seizures and epilepsy in a mentally retarded population over the first 22 years of life. Appl Res Ment Retard. 1980;1(1–2):123–38.

    CAS  PubMed  Google Scholar 

  198. Carlsson M, Hagberg G, Olsson I. Clinical and aetiological aspects of epilepsy in children with cerebral palsy. Dev Med Child Neurol. 2003;45(6):371–6.

    PubMed  Google Scholar 

  199. MacAllister WS, Bender HA, Whitman L, Welsh A, Keller S, Granader Y, et al. Assessment of executive functioning in childhood epilepsy: the Tower of London and BRIEF. Child Neuropsychol. 2012;18(4):404–15.

    PubMed  Google Scholar 

  200. MacAllister WS, Vasserman M, Coulehan K, Hall AF, Bender HA. Cognitive estimations as a measure of executive dysfunction in childhood epilepsy. Child Neuropsychol. 2016;22(1):65–80.

    PubMed  Google Scholar 

  201. Farwell JR, Dodrill CB, Batzel LW. Neuropsychological abilities of children with epilepsy. Epilepsia. 1985;26:395–400.

    CAS  PubMed  Google Scholar 

  202. Neyens LG, Aldenkamp AP, Meinardi HM. Prospective follow-up of intellectual development in children with a recent onset of epilepsy. Epilepsy Res. 1999;34:85–90.

    CAS  PubMed  Google Scholar 

  203. Bailet LL, Turk WR. The impact of childhood epilepsy on neurocognitive and behavioral performance: a prospective longitudinal study. Epilepsia. 2000;41(4):426–31.

    CAS  PubMed  Google Scholar 

  204. Sillanpaa M, Jalava M, Kaleva O, Shinnar S. Long-term prognosis of seizures with onset in childhood. N Engl J Med. 1998;338(24):1715–22.

    CAS  PubMed  Google Scholar 

  205. Hermann B, Seidenberg M. Epilepsy and cognition. Epilepsy Curr. 2007;7(1):1–6.

    PubMed  PubMed Central  Google Scholar 

  206. Taylor J, Kolamunnage-Dona R, Marson AG, Smith PE, Aldenkamp AP, Baker GA. Patients with epilepsy: cognitively compromised before the start of antiepileptic drug treatment? Epilepsia. 2010;51(1):48–56.

    PubMed  Google Scholar 

  207. Hermann BP, Seidenberg M, Dow C, Jones J, Rutecki P, Bhattacharya A, et al. Cognitive prognosis in chronic temporal lobe epilepsy. Ann Neurol. 2006;60(1):80–7.

    PubMed  Google Scholar 

  208. Bjornaes H, Stabell K, Henriksen O, Loyning Y. The effects of refractory epilepsy on intellectual functioning in children and adults. A longitudinal study. Seizure. 2001;10(4):250–9.

    CAS  PubMed  Google Scholar 

  209. Holmes GL. Cognitive impairment in epilepsy: the role of network abnormalities. Epileptic Disord. 2015;17(2):101–16.

    PubMed  PubMed Central  Google Scholar 

  210. Berg AT, Smith SN, Frobish D, Beckerman B, Levy SR, Testa FM, et al. Longitudinal assessment of adaptive behavior in infants and young children with newly diagnosed epilepsy: influences of etiology, syndrome, and seizure control. Pediatrics. 2004;114(3):645–50.

    PubMed  Google Scholar 

  211. Berg AT, Zelko FA, Levy SR, Testa FM. Age at onset of epilepsy, pharmacoresistance, and cognitive outcomes: a prospective cohort study. Neurology. 2012;79(13):1384–91.

    CAS  PubMed  PubMed Central  Google Scholar 

  212. Tromp SC, Weber JW, Aldenkamp AP, Arends J, vander Linden I, Diepman L. Relative influence of epileptic seizures and of epilepsy syndrome on cognitive function. J Child Neurol. 2003;18(6):407–12.

    PubMed  Google Scholar 

  213. Bourgeois BFD, Prensky AL, Palkes HS, Talent BK, Busch SG. Intelligence in epilepsy: a prospective study in children. Ann Neurol. 1983;14:438–44.

    CAS  PubMed  Google Scholar 

  214. Funakoshi A, Morikawa T, Muramatsu R, Yagi K, Seino M. A propsective WISC-R study in children with epilepsy. Jpn J Psychiatry Neurol. 1988;42(3):562–4.

    CAS  PubMed  Google Scholar 

  215. Rodin EA, Schmaltz S, Twitty G. Intellectual functions of patients with childhood-onset epilepsy. Dev Med Child Neurol. 1986;28:25–33.

    CAS  PubMed  Google Scholar 

  216. Berg AT, Lin J, Ebrahimi N, Testa FM, Levy SR, Shinnar S. Modeling remission and relapse in pediatric epilepsy: application of a Markov process. Epilepsy Res. 2004;60(1):31–40.

    PubMed  Google Scholar 

  217. Mandelbaum DE, Burack GD, Bhise VV. Impact of antiepileptic drugs on cognition, behavior, and motor skills in children with new-onset, idiopathic epilepsy. Epilepsy Behav. 2009;16(2):341–4.

    PubMed  Google Scholar 

  218. Ijff DM, Aldenkamp AP. Cognitive side-effects of antiepileptic drugs in children. Handb Clin Neurol. 2013;111:707–18.

    PubMed  Google Scholar 

  219. Moavero R, Santarone ME, Galasso C, Curatolo P. Cognitive and behavioral effects of new antiepileptic drugs in pediatric epilepsy. Brain Dev. 2017;39(6):464–9.

    PubMed  Google Scholar 

  220. Trimble MR, Cull C. Children of school age: the influence of antiepileptic drugs on behavior and intellect. Epilepsia. 1988;29(Suppl 3):S15–9.

    PubMed  Google Scholar 

  221. Trimble MR, Cull CA. Antiepileptic drugs, cognitive function, and behavior in children. Cleve Clin J Med. 1989;56(Suppl Pt 1):S140–6.

    PubMed  Google Scholar 

  222. Farwell JR, Lee YJ, Hirtz DG, Sulzbacher SI, Ellenberg JH, Nelson KB. Phenobarbital for febrile seizures–effects on intelligence and on seizure recurrence. N Engl J Med. 1990;322(6):364–9.

    CAS  PubMed  Google Scholar 

  223. Sulzbacher S, Farwell JR, Temkin N, Lu AS, Hirtz DG. Late cognitive effects of early treatment with phenobarbital. Clin Pediatr (Phila). 1999;38(7):387–94.

    CAS  PubMed  Google Scholar 

  224. Kang HC, Eun BL, Wu Lee C, Ku Moon H, Kim JS, Wook Kim D, et al. The effects on cognitive function and behavioral problems of topiramate compared to carbamazepine as monotherapy for children with benign rolandic epilepsy. Epilepsia. 2007;48(9):1716–23.

    CAS  PubMed  Google Scholar 

  225. Coppola G, Verrotti A, Resicato G, Ferrarelli S, Auricchio G, Operto FF, et al. Topiramate in children and adolescents with epilepsy and mental retardation: a prospective study on behavior and cognitive effects. Epilepsy Behav. 2008;12(2):253–6.

    PubMed  Google Scholar 

  226. Brandl U, Kurlemann G, Neubauer B, Rettig K, Schäuble B, Schreiner A. Seizure and cognitive outcomes in children and adolescents with epilepsy treated with topiramate. Neuropediatrics. 2010;41(3):113–20.

    CAS  PubMed  Google Scholar 

  227. Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, Van Emde BW, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005–2009. Epilepsia. 2010;51(4):676–85.

    PubMed  Google Scholar 

  228. Freitag H, Tuxhorn I. Cognitive function in preschool children after epilepsy surgery: rationale for early intervention. Epilepsia. 2005;46(4):561–7.

    PubMed  Google Scholar 

  229. Jonas R, Asarnow RF, LoPresti C, Yudovin S, Koh S, Wu JY, et al. Surgery for symptomatic infant-onset epileptic encephalopathy with and without infantile spasms. Neurology. 2005;64(4):746–50.

    CAS  PubMed  Google Scholar 

  230. Lux AL, Edwards SW, Hancock E, Johnson AL, Kennedy CR, Newton RW, et al. The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial. Lancet Neurol. 2005;4(11):712–7.

    CAS  PubMed  Google Scholar 

  231. Beaumanoir A. The Landau–Kleffner syndrome. In: Roger J, Bureau M, Dravet C, Dreifuss FE, Perret A, Wolf P, editors. Epileptic syndromes in infancy, childhood and adolescence. 2nd ed. London: John Libbey; 1992. p. 231–43.

    Google Scholar 

  232. Landau WM, Kleffner FR. Syndrome of acquired aphasia with convulsive disorder in children. Neurology. 1957;1957(7):523–30.

    Google Scholar 

  233. Hirsch E, Marescaux C, Maquet P, Metz-Lutz MN, Kiesmann M, Salmon E, et al. Landau–Kleffner Syndrome: a clinical and EEG study of five cases. Epilepsia. 1990;1990(31):756–67.

    Google Scholar 

  234. Lesca G, Rudolf G, Labalme A, Hirsch E, Arzimanoglou A, Genton P, et al. Epileptic encephalopathies of the Landau–Kleffner and continuous spike and waves during slow-wave sleep types: genomic dissection makes the link with autism. Epilepsia. 2012;53(9):1526–38.

    CAS  PubMed  Google Scholar 

  235. Tassinari CA, Rubboli G, Volpi L, Meletti S, d’Orsi G, Franca M, et al. Encephalopathy with electrical status epilepticus during slow sleep or ESES syndrome including the acquired aphasia. Clin Neurophysiol. 2000;111(Suppl 2):S94–102.

    PubMed  Google Scholar 

  236. Gencpinar P, Dundar NO, Tekgul H. Electrical status epilepticus in sleep (ESES)/continuous spikes and waves during slow sleep (CSWS) syndrome in children: An electroclinical evaluation according to the EEG patterns. Epilepsy Behav. 2016;61:107–11.

    PubMed  Google Scholar 

  237. Holmes GL. Interictal spikes as an EEG biomarker of cognitive impairment. J Clin Neurophysiol. 2020 (in press).

  238. Sowell MK, Youssef PE. The comorbidity of migraine and epilepsy in children and adolescents. Semin Pediatr Neurol. 2016;23(1):83–91.

    PubMed  Google Scholar 

  239. Rajapakse T, Buchhalter J. The borderland of migraine and epilepsy in children. Headache. 2016;56(6):1071–80.

    PubMed  Google Scholar 

  240. Mutlu A. Association between epilepsy and headache. Neurol Sci. 2018;39(12):2129–34.

    PubMed  Google Scholar 

  241. Balottin L, Mannarini S, Candeloro D, Mita A, Chiappedi M, Balottin U. Rorschach evaluation of personality and emotional characteristics in adolescents with migraine versus epilepsy and controls. Front Neurol. 2018;9:160.

    PubMed  PubMed Central  Google Scholar 

  242. Kanner AM, Ribot R, Mazarati A. Bidirectional relations among common psychiatric and neurologic comorbidities and epilepsy: do they have an impact on the course of the seizure disorder? Epilepsia Open. 2018;3(Suppl 2):210–9.

    PubMed  PubMed Central  Google Scholar 

  243. Kossoff EH, Andermann F. Migraine and epilepsy. Semin Pediatr Neurol. 2010;17(2):117–22.

    PubMed  Google Scholar 

  244. Andermann F. Migraine and the benign partial epilepsies of childhood: evidence for an association. Epileptic Disord. 2000;2(Suppl 1):S37–9.

    PubMed  Google Scholar 

  245. Papetti L, Nicita F, Parisi P, Spalice A, Villa MP, Kasteleijn-Nolst Trenité DG. “Headache and epilepsy”–how are they connected? Epilepsy Behav. 2013;26(3):386–93.

    PubMed  Google Scholar 

  246. Ludvigsson P, Hesdorffer D, Olafsson E, Kjartansson O, Hauser WA. Migraine with aura is a risk factor for unprovoked seizures in children. Ann Neurol. 2006;59(1):210–3.

    PubMed  Google Scholar 

  247. Ottman R, Lipton RB. Comorbidity of migraine and epilepsy. Neurology. 1994;44(Suppl.7):5–10.

    Google Scholar 

  248. Velioğlu SK, Boz C, Ozmenoğlu M. The impact of migraine on epilepsy: a prospective prognosis study. Cephalalgia. 2005;25(7):528–35.

    PubMed  Google Scholar 

  249. Kacperski J, Green A, Qaiser S. Management of chronic migraine in children and adolescents: a brief discussion on preventive therapies. Paediatr Drugs. 2020;22:635–43.

    PubMed  Google Scholar 

  250. Powers SW, Coffey CS, Chamberlin LA, Ecklund DJ, Klingner EA, Yankey JW, et al. Trial of amitriptyline, topiramate, and placebo for pediatric migraine. N Engl J Med. 2017;376(2):115–24.

    CAS  PubMed  Google Scholar 

  251. Loder E, Rizzoli P. Pharmacologic prevention of migraine: a narrative review of the state of the art in 2018. Headache. 2018;58(Suppl 3):218–29.

    PubMed  Google Scholar 

  252. Kacperski J, Kabbouche MA, O’Brien HL, Weberding JL. The optimal management of headaches in children and adolescents. Ther Adv Neurol Disord. 2016;9(1):53–68.

    CAS  PubMed  PubMed Central  Google Scholar 

  253. Spritzer SD, Bravo TP, Drazkowski JF. Topiramate for treatment in patients with migraine and epilepsy. Headache. 2016;56(6):1081–5.

    PubMed  Google Scholar 

  254. Jackson JL, Cogbill E, Santana-Davila R, Eldredge C, Collier W, Gradall A, et al. A comparative effectiveness meta-analysis of drugs for the prophylaxis of migraine headache. PLoS One. 2015;10(7):e0130733.

    PubMed  PubMed Central  Google Scholar 

  255. Linde M, Mulleners WM, Chronicle EP, McCrory DC. Gabapentin or pregabalin for the prophylaxis of episodic migraine in adults. Cochrane Database Syst Rev. 2013;2013(6):Cd010609.

    PubMed Central  Google Scholar 

  256. Linde M, Mulleners WM, Chronicle EP, McCrory DC. Antiepileptics other than gabapentin, pregabalin, topiramate, and valproate for the prophylaxis of episodic migraine in adults. Cochrane Database Syst Rev. 2013;24(6):Cd010608.

    Google Scholar 

  257. Patniyot IR, Gelfand AA. Acute treatment therapies for pediatric migraine: a qualitative systematic review. Headache. 2016;56(1):49–70.

    PubMed  Google Scholar 

  258. Major PW, Grubisa HS, Thie NM. Triptans for treatment of acute pediatric migraine: a systematic literature review. Pediatr Neurol. 2003;29(5):425–9.

    PubMed  Google Scholar 

  259. Jacob J, Goadsby PJ, Duncan JS. Use of sumatriptan in post-ictal migraine headache. Neurology. 1996;47(4):1104.

    CAS  PubMed  Google Scholar 

  260. Kanner AM. Management of psychiatric and neurological comorbidities in epilepsy. Nat Rev Neurol. 2016;12(2):106–16.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurological Sciences, Larner College of Medicine, University of Vermont, Stafford Hall, 118C, Burlington, VT, 05405, USA

    Gregory L. Holmes

Authors
  1. Gregory L. Holmes
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gregory L. Holmes.

Ethics declarations

Funding

This work was supported by the NIH (NINDS) Grants NS108765; NS108296.

Conflict of interest

The author declares that he has no competing interests.

Ethics approval

Not applicable.

Consent to participate

Not applicable.

Consent for publication

Not applicable.

Availability of data and material

All articles cited are available in PubMed.

Code availability

Not applicable.

Author contributions

The author was the sole contributor to this paper.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Holmes, G.L. Drug Treatment of Epilepsy Neuropsychiatric Comorbidities in Children. Pediatr Drugs 23, 55–73 (2021). https://doi.org/10.1007/s40272-020-00428-w

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40272-020-00428-w

Search

Navigation